APA (7th ed.) Citation

A, B., M, B., H, P., LB, W., L, P., L, C., . . . M, S. (2021). Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1. Drug design, development and therapy, 15, 5035. https://doi.org/10.2147/DDDT.S323077

Chicago Style (17th ed.) Citation

A, Bourafai-Aziez, et al. "Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1." Drug Design, Development and Therapy 15 (2021): 5035. https://doi.org/10.2147/DDDT.S323077.

MLA (9th ed.) Citation

A, Bourafai-Aziez, et al. "Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1." Drug Design, Development and Therapy, vol. 15, 2021, p. 5035, https://doi.org/10.2147/DDDT.S323077.